Unlearn has secured a substantial $50M in Series C funding to propel the creation of digital twins for clinical trial participants. Spearheaded by Altimeter Capital, this latest financial influx comes with the support of multiple existing backers.

The San Francisco-based AI innovator is set to channel these funds into further research and development, advancing its groundbreaking technology designed to transform the realm of clinical trials.